monobenzone

agerite alba p- benzoxyphenol para- benzoxyphenol 4-( benzyl oxy) phenol benzyl p-hydroxyphenyl ether benzyl para-hydroxyphenyl ether 4-( benzyl-oxy)phenol 4- benzyloxy phenol 4- benzyloxy-phenol p-( benzyloxy) phenol 4-( benzyloxy)benzolol 4-( benzyloxy)phenol p-( benzyloxy)phenol 4-( benzyloxyl)phenol 4- benzyloxyphenol p- benzyloxyphenol hydroquinone monobenzyl ether p- hydroxyphenyl benzyl ether phenol, 4-(phenylmethoxy)- phenol, 4-benzyloxy- phenol, p-(benzyloxy)- 4-( phenylmethoxy)phenol 4- phenylmethoxyphenol PubMed: Different effects of five depigmentary compounds, rhododendrol, raspberry ketone, monobenzone, rucinol and AP736 on melanogenesis and viability of human epidermal melanocytes. PubMed: A mouse model of vitiligo induced by monobenzone. PubMed: Monobenzone-induced depigmentation: from enzymatic blockade to autoimmunity. PubMed: Successful treatment of extensive vitiligo with monobenzone. PubMed: Skin-depigmenting agent monobenzone induces potent T-cell autoimmunity toward pigmented cells by tyrosinase haptenation and melanosome autophagy. PubMed: The therapeutic effects of EGCG on vitiligo. PubMed: Effective melanoma immunotherapy in mice by the skin-depigmenting agent monobenzone and the adjuvants imiquimod and CpG. PubMed: Pre-clinical evidences of Pyrostegia venusta in the treatment of vitiligo. PubMed: A reactive ortho-quinone generated by tyrosinase-catalyzed oxidation of the skin depigmenting agent monobenzone: self-coupling and thiol-conjugation reactions and possible implications for melanocyte toxicity. PubMed: Corneal and conjunctival effects of monobenzone in patients with vitiligo. PubMed: Monobenzone, Superfade, vitiligo and confetti-like depigmentation. PubMed: Dermatitis produced by applications of monobenzone in patients with active vitiligo. PubMed: Diffuse leukoderma following use of monobenzone. PubMed: MONOBENZONE. PubMed: Evaluation of monobenzone. PubMed: Enhanced bleaching treatment: opportunities for immune-assisted melanocyte suicide in vitiligo. PubMed: Breaking immunological tolerance to melanocyte differentiation antigens by hypopigmenting agents: a new means for melanoma immunotherapy? PubMed: Targeting melanocyte and melanoma stem cells by 8-hydroxy-2-dipropylaminotetralin. PubMed: Accelerating bleaching in vitiligo: balancing benefits versus risks. PubMed: Preferential secretion of inducible HSP70 by vitiligo melanocytes under stress. PubMed: Vitiligo-inducing phenols activate the unfolded protein response in melanocytes resulting in upregulation of IL6 and IL8. PubMed: Depigmentation therapies for normal skin in vitiligo universalis. PubMed: The development of guidelines for the treatment of vitiligo. Clinical Epidemiology Unit of the Istituto Dermopatico dell'Immacolata-Istituto di Recovero e Cura a Carattere Scientifico (IDI-IRCCS) and the Archives of Dermatology. PubMed: How we treat vitiligo. PubMed: Monobenzyl ether of hydroquinone and 4-tertiary butyl phenol activate markedly different physiological responses in melanocytes: relevance to skin depigmentation. PubMed: New and experimental treatments of vitiligo and other hypomelanoses. PubMed: Retinoic acid synergistically enhances the melanocytotoxic and depigmenting effects of monobenzylether of hydroquinone in black guinea pig skin. PubMed: Footwear depigmentation. PubMed: Rapid repigmentation after depigmentation therapy: vitiligo treated with monobenzyl ether of hydroquinone. PubMed: Achromic patch test from hydroquinone monobenzyl ether. PubMed: The Seiji memorial lecture. Pigment stories: from vitiligo to melanomas and points in between. PubMed: Contact depigmentation of the breast. PubMed: Should vitiligo be treated? PubMed: [Leukomelanodermia areata (dyschromia "en confetti") caused by the application of monobenzylether of hydroquinone (author's transl)]. PubMed: [Irreversible toxic depigmentation. Observations following use of hydroquinonemonobenzylether-containing skin bleaching preparations]. PubMed: Contact hypersensitivity to monobenzyl ether of hydroquinone used to treat vitiligo. PubMed: Dyschromatosis. PubMed: A case report of extensive vitiligo. PubMed: Treatment of nonhairy melanocytic macules by dermabrasion and topical application of 5% hydroquinone monobenzyl ether cream. PubMed: Hearing aid depigmentation. PubMed: Influence of depigmenting chemical agents on hair and skin color in yellow (pheomelanic) and black (eumelanic) mice. PubMed: [Confetti-like dyschromia caused by a bleaching cream containing hydroquinone in racially pigmented patients]. PubMed: Modulation of the population density of identifiable epidermal Langerhans cells associated with enhancement or suppression of cutaneous immune reactivity. PubMed: [Treatment of vitiligo]. PubMed: [Therapy of melanin-induced pigment anomalies]. PubMed: Sensitization to hydroquinone and the monobenzyl ether of hydroquinone. PubMed: [Acquired leukomelanoderma caused by topical depigmenting agents]. PubMed: Screening of depigmenting compounds for the development of an alternate method of branding beef cattle. PubMed: [Eye diseases attributable to dermatologic therapy]. PubMed: Vitiligo: a manifestation of apoptosis? PubMed: Vitiligo. PubMed: Cutaneous reactions to topical application of hydroquinone. Results of a 6-year investigation.